BACKGROUND. Recent studies conducted in individuals who survived COVID-19 suggest that SARS-CoV-2 infection is associated with an increased risk of dyslipidemia. However, it remains unclear whether this augmented risk is confirmed in the general population and how this phenomenon is affecting the overall burden of cardiometabolic diseases.

中文翻译：

---

一项对真实世界人群进行的为期六年的研究显示，COVID-19 期间血脂异常的发生率增加


背景。 最近对 COVID-19 幸存者进行的研究表明，SARS-CoV-2 感染与血脂异常风险增加有关。然而，目前尚不清楚这种增加的风险是否在普通人群中得到证实，以及这种现象如何影响心脏代谢疾病的总体负担。